Reference
Direct Healthcare Professional Communication (DHPC): Citalopram and Escitalopram - Risk of Dose-dependent QT interval Prolongation Internet Document : 14 Jul 2022. Available from: URL: https://www.edaegypt.gov.eg/media/cyak3pvr/150-newsletter-hundred-fifty-july-2022.pdf
Rights and permissions
About this article
Cite this article
Citalopram, escitalopram, risk of dose-dependent QT-interval prolongation. Reactions Weekly 1916, 2 (2022). https://doi.org/10.1007/s40278-022-19461-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-19461-y